| Recruitment status | Main results already published |
| Unique ID issued by UMIN | UMIN000013810 |
| Receipt No. | R000016118 |
| Official scientific title of the study | Study on the possible differential diagnosis of dementia using the measurement of the uniformity of the EEG potential distribution |
| Date of disclosure of the study information | 2014/04/26 |
| Last modified on | 2016/05/04 (Ver. 9) |
| Basic information | ||
| Official scientific title of the study | Study on the possible differential diagnosis of dementia using the measurement of the uniformity of the EEG potential distribution | |
| Title of the study (Brief title) | Study on the possible differential diagnosis of dementia using the measurement of the uniformity of the EEG potential distribution | |
| Region |
|
|
| Condition | ||
| Condition | Mild Cognitive Impairment (MCI) | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | Validation of the effect of the interventions for the individuals with Mild Cognitive Impairment |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Neuronal activity measued using the electroencephalography (EEG) records |
| Key secondary outcomes | |
| In outcomes field, the entry of just a few words such as "safety" or "efficiency" will not be accepted. Specify the name of outcome measures, including the time when you plan to measure. Usually, only one primary outcome is accepted. Write the other outcomes in "secondary outcomes" field. |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Cross-over |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | No treatment |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Prevention | |
| Type of intervention |
|
|
| Interventions/Control_1 | exercise | |
| Interventions/Control_2 | control | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| In interventions field, include the details of interventions, such as duration, amount, and frequency. If the intervention includes prescription or use of medical devices, duration is required. |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Mild cognitive impairment(MCI) patients | |||
| Key exclusion criteria | not applicable | |||
| Target sample size | 35 | |||
| Research contact person | |
| Name of lead principal investigator | Takashi Asada |
| Organization | University of Tsukuba |
| Division name | Department of Psychiatry |
| Address | 1-1-1 Tennodai, Tsukuba, Ibaraki 305-8575 Japan |
| TEL | 029-853-3182 |
| tasada@md.tsukuba.ac.jp | |
| Public contact | |
| Name of contact person | Takashi Asada |
| Organization | University of Tsukuba |
| Division name | Department of Psychiatry |
| Address | 1-1-1 Tennodai, Tsukuba, Ibaraki 305-8575 Japan |
| TEL | 029-853-3182 |
| Homepage URL | |
| tasada@md.tsukuba.ac.jp | |
| Sponsor | |
| Institute | Department of Psychiatry, University of Tsukuba |
| Institute | |
| Department | |
| Sponsor means an organization that is responsible for plan, deployment and report of the research including funding management. It doesn't mean funding agency". Therefore, all clinical trial should have the one. |
| Funding Source | |
| Organization | Japan Science and Technology Agency, RISTEX |
| Organization | |
| Division | |
| Category of Funding Organization | Japanese Governmental office |
| Nationality of Funding Organization | Japan |
| Other related organizations | |
| Co-sponsor | Brain Functions Laboratory, Inc.
RENAISSANCE INC. |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 筑波大学附属病院(茨城県) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Main results already published | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Partially published |
| URL releasing results | http://www2.convention.co.jp/jsdr34/files/jsdr34_program_ippan.pdf |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000016118 |